Effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer activity

Area of Science:

• Immunology
• Cellular Immunology
• Cancer Immunology

Background:

• Lymphokine-activated killer (LAK) cells are crucial for anti-tumor immunity.
• Interleukin-2 (IL-2) and Interleukin-4 (IL-4) are key cytokines in immune responses.
• The role of macrophages in modulating LAK cell activity requires further elucidation.

Purpose of the Study:

• To investigate the effect of macrophages on IL-2 and IL-4-induced LAK activity in mice.
• To determine if macrophages enhance LAK activity against various tumor cell lines.
• To explore the surface marker expression of LAK effector cells generated with macrophage support.

Main Methods:

• Accessory cell-depleted splenic lymphocytes were cultured with IL-2 or IL-4 in the presence or absence of peritoneal macrophages.
• LAK activity was assessed against natural killer (NK)-sensitive and NK-resistant tumor cell lines.
• Surface marker analysis using negative selection with antibodies and complement was performed on effector cells.

Main Results:

• Peritoneal macrophages significantly enhanced LAK activity in both IL-2 and IL-4 cultures.
• This enhancement was dose-dependent on the number of macrophages.
• Macrophages boosted LAK activity against both NK-sensitive and NK-resistant tumor cells, and no differences in surface markers were observed between IL-2 and IL-4 LAK effectors generated with macrophages.

Conclusions:

• Macrophages play a significant role in enhancing IL-2 and IL-4-induced LAK activity.
• The enhancing effect is macrophage-dependent and not mediated by soluble factors.
• The findings suggest that macrophages can enhance the same LAK effector subsets regardless of whether IL-2 or IL-4 is used for induction.